Sarfaraz Ali - Aug 9, 2022 Form 4 Insider Report for Novo Integrated Sciences, Inc. (NVOS)

Role
Director
Signature
/s/ Sarfaraz Ali
Stock symbol
NVOS
Transactions as of
Aug 9, 2022
Transactions value $
$0
Form type
4
Date filed
8/10/2022, 01:01 PM
Previous filing
Aug 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVOS Stock Option (right to buy) Award $0 +39.5K $0.00 39.5K Aug 9, 2022 Common Stock 39.5K $1.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant, pursuant to the issuer's 2021 Equity Incentive Plan, approved by the issuer's Board of Directors. The stock option vests, and becomes exercisable, with respect to 3,290 shares each month, beginning on the date of grant, until August 9, 2023.